In this study, we observed that plasma GFAP distinguished NIID from HCs and increased before the onset of clinical symptoms, thereby highlighting its potential as a diagnostic and predictive biomarker for NIID. Here, GFAP is linked to neuronal intranuclear inclusion disease.